Primary Cardiac Sarcoma of the Left Atrium, A Case Report and Literature Review

G. Negamiyimana, J. Bagorane, G. Adjadé, J. Meunier, M. E. Fadli, R. Belbaraka
{"title":"Primary Cardiac Sarcoma of the Left Atrium, A Case Report and Literature Review","authors":"G. Negamiyimana, J. Bagorane, G. Adjadé, J. Meunier, M. E. Fadli, R. Belbaraka","doi":"10.36348/gajms.2022.v04i03.004","DOIUrl":null,"url":null,"abstract":"Primary malignant cardiac tumours are extremely rare. They count for a quarter of all possible cardiac tumors, and are mostly sarcomas. For a long time, their diagnosis was made post mortem, and they were only reported through autopsy series. Since then, diagnostic and therapeutic advances have been made, making clinical diagnosis of this entity more accessible ante mortem. Nevertheless, due to their rarity, cardiac sarcomas suffer from a lack of therapeutic guidelines. Their treatment is modelled on that of sarcomas developed in other organs of the body. We report an interesting case of a 74-year-old female patient operated on for an infiltrating sarcomatous tumour of the left atrium revealed by dyspnoea associated with cardiac palpitations. Thoracic angioscan and transthoracic echocardiography led to the diagnosis of a cardiac tumour, and the thoracic-abdominal-pelvic Computed Tomography (CT) scan did not reveal any other extracardiac lesions except for a minimal non-neoplastic bilateral pleural effusion. The patient underwent an incomplete surgical procedure with R2 resection followed by adjuvant chemotherapy with doxorubicin monotherapy. The evolution under this treatment was marked by a locoregional progression of the disease with further progression in the atria, mediastinum and dorsal spine after 4 courses. A second line of chemotherapy with Dacarbazine monotherapy was initiated, but the patient died shortly after receiving two courses of the new treatment.","PeriodicalId":397187,"journal":{"name":"Global Academic Journal of Medical Sciences","volume":"35 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Academic Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/gajms.2022.v04i03.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Primary malignant cardiac tumours are extremely rare. They count for a quarter of all possible cardiac tumors, and are mostly sarcomas. For a long time, their diagnosis was made post mortem, and they were only reported through autopsy series. Since then, diagnostic and therapeutic advances have been made, making clinical diagnosis of this entity more accessible ante mortem. Nevertheless, due to their rarity, cardiac sarcomas suffer from a lack of therapeutic guidelines. Their treatment is modelled on that of sarcomas developed in other organs of the body. We report an interesting case of a 74-year-old female patient operated on for an infiltrating sarcomatous tumour of the left atrium revealed by dyspnoea associated with cardiac palpitations. Thoracic angioscan and transthoracic echocardiography led to the diagnosis of a cardiac tumour, and the thoracic-abdominal-pelvic Computed Tomography (CT) scan did not reveal any other extracardiac lesions except for a minimal non-neoplastic bilateral pleural effusion. The patient underwent an incomplete surgical procedure with R2 resection followed by adjuvant chemotherapy with doxorubicin monotherapy. The evolution under this treatment was marked by a locoregional progression of the disease with further progression in the atria, mediastinum and dorsal spine after 4 courses. A second line of chemotherapy with Dacarbazine monotherapy was initiated, but the patient died shortly after receiving two courses of the new treatment.
原发性左心房心脏肉瘤1例报告并文献复习
原发性恶性心脏肿瘤极为罕见。它们占所有可能的心脏肿瘤的四分之一,并且大多数是肉瘤。长期以来,他们的诊断是在死后做出的,只通过尸检系列报道。从那时起,诊断和治疗取得了进步,使这种实体的临床诊断更容易在死前进行。然而,由于其罕见性,心脏肉瘤缺乏治疗指南。他们的治疗方法是模仿在身体其他器官中发展的肉瘤。我们报告一个有趣的病例,74岁的女性患者的左心房浸润性肉瘤肿瘤的手术显示呼吸困难与心悸。胸部血管扫描和经胸超声心动图诊断为心脏肿瘤,胸腹盆腔计算机断层扫描(CT)除少量非肿瘤性双侧胸腔积液外,未发现任何其他心外病变。患者接受了R2切除的不完全手术,随后进行了阿霉素单药辅助化疗。在这种治疗下,病情的发展以局部进展为标志,在4个疗程后,心房、纵隔和脊柱背进一步进展。第二次化疗开始使用达卡巴嗪单药治疗,但患者在接受两个疗程的新治疗后不久死亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信